Kamila Czene - Epidemiology

Author Information

K. Czene is a prominent researcher affiliated with the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet in Stockholm, Sweden. Their primary area of focus appears to be the epidemiology of breast cancer, as indicated by their extensive publication record in this field.

Research Contributions

K. Czene has made significant contributions to the field of breast cancer research. The author's work in 2022 alone includes multiple studies addressing various aspects of breast cancer, such as the risk associated with menopausal hormonal therapy, genetic susceptibility, gene-environment interactions, and pathology of tumors linked to germline variants. Other notable studies explore the association between breast cancer and interferon immune response, the risk of heart disease following breast cancer treatment, and rare germline copy number variants. This body of work highlights K. Czene's dedication to advancing our understanding of breast cancer through both genetic and epidemiological lenses.

Aliases

K. Czene is also known by other names, including K Czene and Kamila Czene.

Publication and Citation Metrics

Metric	Value
Total Citation Count	24,877
H-index	77
Total Paper Count	549

Publications:

Circulating proteins reveal prior use of menopausal hormonal therapy and increased risk of breast cancer

DOI: 10.1016/j.tranon.2022.101339

Year: 2022

A Swedish Genome-Wide Haplotype Association Analysis Identifies a Novel Breast Cancer Susceptibility Locus in 8p21.2 and Characterizes Three Loci on Chromosomes 10, 11 and 16

DOI: 10.3390/cancers14051206

Year: 2022

A genome-wide gene-based gene-environment interaction study of breast cancer in more than 90,000 women

DOI: 10.1158/2767-9764.crc-21-0119

Year: 2022

Interval breast cancer is associated with interferon immune response

DOI: 10.1016/j.ejca.2021.12.003

Year: 2022

Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women

DOI: 10.1038/s41598-022-10121-2

Year: 2022

Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci

DOI: 10.1186/s13058-022-01524-0

Year: 2022

Rare germline copy number variants (CNVs) and breast cancer risk

DOI: 10.1038/s42003-021-02990-6

Year: 2022

Risk of heart disease following treatment for breast cancer – results from a population-based cohort study

DOI: 10.7554/eLife.71562

Year: 2022

Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes

DOI: 10.1001/jamaoncol.2021.6744

Year: 2022

Pregnancy Outcomes in Women With a Prior Cervical Intraepithelial Neoplasia Grade 3 Diagnosis

DOI: 10.7326/M21-2793

Year: 2022

How Does RBT Work?

What are the Challenges in Studying Well-being?

Why is Reperfusion Therapy Important?

What is the Polio Eradication Initiative?

Who are the Key Players in Intersectoral Collaboration?

What is Competitive Selection?

What are Differential Equations?

How Do Environmental Exposures Differ?

What are the risk factors for kidney disease?

Why are the IHR important in Epidemiology?

Partnered Content Networks

Relevant Topics